ALX Oncology

0 followers

‌

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.

Industries

Biotechnology

Headquarters

Burlingame, United States

Employees

11-50

Links

Org chart

Sophia Randolph

Chief Medical Officer

Athanasios Tsiatis

SVP, Clinical Development

Yeong-Liang Lin

SVP, Drug Safety & Pharmacovigilance

Hank Stern

VP, Chemistry, Manufacturing & Controls

Susan Vermeir

VP, Regulatory Affairs & Quality

Hadi Falahatpisheh

VP, Preclinical Development

Marija Vrljic

VP, Antibody Technologies

Jeanne Jew

Chief Business Officer

Linda Woo

Director Of Clinical Operations

Board & advisors

Corey Goodman

Executive Chairman, Board of Directors

Board Member

CEO

Board Member

Chairman, Scientific Advisory Board

Charles M. Baum

Advisor

Kipp Weiskopf

Advisor

Scott Garland

Director

Teams

Clinical Development and Operations

5 people · 0 jobs

Leadership Team

7 people · 0 jobs

Regulatory Affairs and Compliance

5 people · 0 jobs

Offices

HQ
10 positions, 0 job posts
DO
+6

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

14 followers

PerkinElmer

11 followers

Explore companies